These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 25464974)

  • 21. Design, synthesis and biological evaluation of potent NAD+-dependent DNA ligase inhibitors as potential antibacterial agents. Part 2: 4-amino-pyrido[2,3-d]pyrimidin-5(8H)-ones.
    Wang T; Duncan L; Gu W; O'Dowd H; Wei Y; Perola E; Parsons J; Gross CH; Moody CS; Arends SJ; Charifson PS
    Bioorg Med Chem Lett; 2012 Jun; 22(11):3699-703. PubMed ID: 22560470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and structure-activity studies of novel anhydrohexitol-based Leucyl-tRNA synthetase inhibitors.
    De Ruysscher D; Pang L; Lenders SMG; Cappoen D; Cos P; Rozenski J; Strelkov SV; Weeks SD; Van Aerschot A
    Eur J Med Chem; 2021 Feb; 211():113021. PubMed ID: 33248851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery and Characterization of a Class of Pyrazole Inhibitors of Bacterial Undecaprenyl Pyrophosphate Synthase.
    Concha N; Huang J; Bai X; Benowitz A; Brady P; Grady LC; Kryn LH; Holmes D; Ingraham K; Jin Q; Pothier Kaushansky L; McCloskey L; Messer JA; O'Keefe H; Patel A; Satz AL; Sinnamon RH; Schneck J; Skinner SR; Summerfield J; Taylor A; Taylor JD; Evindar G; Stavenger RA
    J Med Chem; 2016 Aug; 59(15):7299-304. PubMed ID: 27379833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery and characterization of tRNAIle lysidine synthetase (TilS).
    Suzuki T; Miyauchi K
    FEBS Lett; 2010 Jan; 584(2):272-7. PubMed ID: 19944692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.
    Lv PC; Sun J; Luo Y; Yang Y; Zhu HL
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4657-60. PubMed ID: 20594840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibacterial Activity and Mode of Action of a Sulfonamide-Based Class of Oxaborole Leucyl-tRNA-Synthetase Inhibitors.
    Si Y; Basak S; Li Y; Merino J; Iuliano JN; Walker SG; Tonge PJ
    ACS Infect Dis; 2019 Jul; 5(7):1231-1238. PubMed ID: 31007018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of a potent enoyl-acyl carrier protein reductase (FabI) inhibitor suitable for antistaphylococcal agent.
    Kim YG; Seo JH; Kwak JH; Shin KJ
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4481-6. PubMed ID: 26343826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel boronic acid derivatives of bis(indolyl) methane as anti-MRSA agents.
    Mandal SM; Pegu R; Porto WF; Franco OL; Pratihar S
    Bioorg Med Chem Lett; 2017 May; 27(10):2135-2138. PubMed ID: 28377058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and antibacterial activities of vanillic acylhydrazone derivatives as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
    Wang XL; Zhang YB; Tang JF; Yang YS; Chen RQ; Zhang F; Zhu HL
    Eur J Med Chem; 2012 Nov; 57():373-82. PubMed ID: 23124163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of a novel azaindole class of antibacterial agents targeting the ATPase domains of DNA gyrase and Topoisomerase IV.
    Manchester JI; Dussault DD; Rose JA; Boriack-Sjodin PA; Uria-Nickelsen M; Ioannidis G; Bist S; Fleming P; Hull KG
    Bioorg Med Chem Lett; 2012 Aug; 22(15):5150-6. PubMed ID: 22814212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metronidazole containing pyrazole derivatives potently inhibit tyrosyl-tRNA synthetase: design, synthesis, and biological evaluation.
    Chen LW; Wang PF; Tang DJ; Tao XX; Man RJ; Qiu HY; Wang ZC; Xu C; Zhu HL
    Chem Biol Drug Des; 2016 Oct; 88(4):592-8. PubMed ID: 27206529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibacterial inhibitors of Gram-positive thymidylate kinase: structure-activity relationships and chiral preference of a new hydrophobic binding region.
    Kawatkar SP; Keating TA; Olivier NB; Breen JN; Green OM; Guler SY; Hentemann MF; Loch JT; McKenzie AR; Newman JV; Otterson LG; Martínez-Botella G
    J Med Chem; 2014 Jun; 57(11):4584-97. PubMed ID: 24828090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spotlight on targeting aminoacyl-tRNA synthetases for the treatment of fungal infections.
    Ferrer E
    Drug News Perspect; 2006; 19(6):347-8. PubMed ID: 16971970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis and antibacterial activity of 3-methylenepyrrolidine formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
    Shi W; Ma H; Duan Y; Aubart K; Fang Y; Zonis R; Yang L; Hu W
    Bioorg Med Chem Lett; 2011 Feb; 21(3):1060-3. PubMed ID: 21185180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitors of aminoacyl-tRNA synthetases as antimycobacterial compounds: An up-to-date review.
    Bouz G; Zitko J
    Bioorg Chem; 2021 May; 110():104806. PubMed ID: 33799176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and antibacterial evaluation of rhodanine-based 5-aryloxy pyrazoles against selected methicillin resistant and quinolone-resistant Staphylococcus aureus (MRSA and QRSA).
    Song MX; Zheng CJ; Deng XQ; Sun LP; Wu Y; Hong L; Li YJ; Liu Y; Wei ZY; Jin MJ; Piao HR
    Eur J Med Chem; 2013 Feb; 60():376-85. PubMed ID: 23314051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel inhibitors of Staphylococcus aureus RnpA that synergize with mupirocin.
    Lounsbury N; Eidem T; Colquhoun J; Mateo G; Abou-Gharbia M; Dunman PM; Childers WE
    Bioorg Med Chem Lett; 2018 Apr; 28(6):1127-1131. PubMed ID: 29463447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting the Bacterial Epitranscriptome for Antibiotic Development: Discovery of Novel tRNA-(N
    Zhong W; Koay A; Ngo A; Li Y; Nah Q; Wong YH; Chionh YH; Ng HQ; Koh-Stenta X; Poulsen A; Foo K; McBee M; Choong ML; El Sahili A; Kang C; Matter A; Lescar J; Hill J; Dedon P
    ACS Infect Dis; 2019 Mar; 5(3):326-335. PubMed ID: 30682246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of novel dinitrobenzotrifluoride containing o-hydroxybenzylamine derivatives as potential antibacterial agents.
    Li QS; Ni HJ; Yang Y; Lv XH; Ruan BF
    Med Chem; 2015; 11(3):305-13. PubMed ID: 25219926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and characterization of novel small molecule inhibitors of the acetyltransferase activity of Escherichia coli N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU).
    Sharma R; Rani C; Mehra R; Nargotra A; Chib R; Rajput VS; Kumar S; Singh S; Sharma PR; Khan IA
    Appl Microbiol Biotechnol; 2016 Apr; 100(7):3071-85. PubMed ID: 26563552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.